IP Library Granted Patent US 9,921,233
Granted Patent B2
US 9,921,233 · App. 14/880,623 · Granted Mar 20, 2018

Combined DESI and optical imaging analysis of tissues

Inventors: Robert Graham Cooks (West Lafayette, IN); Livia Schiavinato Eberlin (Lafayette, IN); Christina Ramires Ferreira (West Lafayette, IN); Allison Lisa Dill (Indianapolis, IN); Demian R. Ifa (West Lafayette, IN)
Assignee: Purdue Research Foundation
G01N33/92H01J49/0036H01J49/165H01J49/0004H01J49/142
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,921,233
App. No.
14/880,623
Granted
Mar 20, 2018
Kind
B2
Abstract

The invention generally relates to mass spectral analysis. In certain embodiments, methods of the invention involve analyzing a lipid containing sample using a mass spectrometry technique, in which the technique utilizes a liquid phase that does not destroy native tissue morphology during analysis.

Claims (31)

1. A method for analyzing a tissue sample, the method comprising:

performing a mass spectral analysis of a tissue sample using a desorption electrospray ionization (DESI) technique that comprises directing a liquid phase that does not destroy native tissue morphology from a DESI probe onto the tissue sample to thereby desorb one or more lipids, peptides, or proteins from the sample that are analyzed by a mass spectrometer;

producing a mass spectral image of the tissue sample based on results of the mass spectral analysis;

performing a histochemistry analysis technique on the sample to thereby stain the sample;

producing an optical image of the stained sample;

overlaying the mass spectral image with the optical image of the stained sample to produce an overlaid image; and

determining a distribution of the one or more lipids, peptides, or proteins in the tissue sample based on an analysis of the overlaid image.

2. The method of claim 1 , wherein the liquid phase is a solvent comprising dimethylformamide (DMF), acetonitrile (ACN), or tetrahydrofuran (THF).

3. The method according to claim 2 , wherein the liquid phase comprises at least one other component.

4. The method according to claim 3 , wherein the at least one other component is selected from the group consisting of ethanol (EtOH), water (H 2 O), acetonitrile (ACN), and a combination thereof.

5. The method according to claim 1 , wherein the liquid phase is selected from the group consisting of: acetonitrile (ACN):ethanol (EtOH); methanol (MeOH):chloroform (CHCl 3 ); and acetonitrile (ACN):chloroform (CHCl 3 ).

6. The method according to claim 1 , wherein the histochemistry analysis technique is H&E staining.

7. The method according to claim 1 , wherein the one or more lipids are analyzed by the mass spectrometer.

8. The method according to claim 1 , wherein the ionization probe is a desorption electrospray ionization probe.

9. The method according to claim 1 , further comprising determining whether an abnormality exists in the tissue sample based on the distribution of the one or more lipids, peptides, or proteins in the tissue sample.

10. The method according to claim 9 , wherein the abnormality is a cancer.

11. A method for detecting cancerous tissue within a tissue sample, the method comprising:

performing a mass spectral analysis of a tissue sample using a desorption electrospray ionization (DESI) technique that comprises directing a liquid phase that does not destroy native tissue morphology from lipids, peptides, or proteins a DESI probe onto the tissue sample to thereby desorb one or more lipids, peptides, or proteins from the sample that are analyzed by a mass spectrometer;

producing a mass spectral image of the tissue sample based on results of the mass spectral analysis;

performing a histochemistry analysis technique on the sample to thereby stain the sample;

producing an optical image of the stained sample;

overlaying the mass spectral image with the optical image of the stained sample to produce an overlaid image; and

detecting cancerous tissue within the tissue sample based on an analysis of the overlaid image.

12. The method of claim 11 , wherein the liquid phase is a solvent comprising dimethylformamide (DMF), acetonitrile (ACN), or tetrahydrofuran (THF).

13. The method according to claim 12 , wherein the liquid phase comprises at least one other component.

14. The method according to claim 13 , wherein the at least one other component is selected from the group consisting of ethanol (EtOH), water (H 2 O), acetonitrile (ACN), and a combination thereof.

15. The method according to claim 11 , wherein the liquid phase is selected from the group consisting of: acetonitrile (ACN):ethanol (EtOH); methanol (MeOH):chloroform (CHCl 3 ); and acetonitrile (ACN):chloroform (CHCl 3 ).

16. The method according to claim 11 , wherein the histochemistry analysis technique is H&E staining.

17. The method according to claim 11 , wherein the one or more lipids are analyzed by the mass spectrometer.

18. The method according to claim 11 , wherein the ionization probe is a desorption electrospray ionization probe.

19. The method according to claim 11 , wherein the desorption electrospray ionization probe operates at atmospheric pressure and temperature.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2021
From: COOKS, ROBERT GRAHAM; EBERLIN, LIVIA SCHIAVINATO; FERREIRA, CHRISTINA RAMIRES; DILL, ALLISON LISA; IFA, DEMIAN R.
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 056314/0980 →
CONFIRMATORY LICENSE Recorded Sep 25, 2017
From: PURDUE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043987/0461 →
Continuity (3)
Continuation 13475305 · May 18, 2012
Provisional Application 61487363 · May 18, 2011
Related Publication 20160047831A1 · Feb 18, 2016